project id: TCGA-SKCM; case submitter id: TCGA-FS-A1ZR; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 8.7; age at index: 36; days to birth: -13325; days to death: 347; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1959; year of death: 1995; age at diagnosis: 13325; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 4th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C77.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lymph node, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 1995; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 5645; initial weight: 100.0; oct embedded: false; preservation method: Unknown; sample id: 4eec8951-5b1b-4881-bbc9-2b4c2c4fcd16; sample submitter id: TCGA-FS-A1ZR-06A; portion id: 15639607-9623-4248-b98d-474b6ca6ca90; portion submitter id: TCGA-FS-A1ZR-06A-21; slide id: 4e610b8e-59a4-4db3-b129-01eeada9d92b; slide submitter id: TCGA-FS-A1ZR-06A-02-TSB; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 65.0; percent stromal cells: 0.0; percent tumor cells: 35.0; percent tumor nuclei: 65.0; section location: TOP;